President Biden delivered a speech yesterday highlighting the drug pricing reform measures in the Build Back Better Act — especially for insulin products — shortly after Sen. Majority Leader Chuck Schumer (D-N.Y.) released a letter outlining Democratic attempts to pass the $2 trillion bill by Christmas.
Source: Drug Industry Daily